Manish Sahni, MD , our team provides comprehensive metabolic support to help patients navigate the physiological changes associated with GLP-1 therapy
Rachel Sorvig, a spokesperson for Zepbound and Mounjaro manufacturer Eli Lilly, said in a statement that users should talk to their health care provider about dosage and duration needs. Studies have shown that people typically regain a substantial amount of weight within a year of stopping GLP-1 medications, and that many people who quit ultimately go back on the drugs
Who should discuss their situation with a primary care provider before starting Omzo or any GLP-1 telehealth program: individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, or other conditions that may be contraindicated with GLP-1 receptor agonists
Its a good idea to use one of these, to help keep your medication fresh for as long as possible
It's produced by specialized L-cells in your intestine, and one of the most powerful natural triggers for its release is a group of compounds made by your gut bacteria when they ferment fiber